Article

Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease.

2022-12-30

Abstract excerpt

<title>Abstract</title> <p>To date there are no therapeutic strategies that limit the progression of Parkinson’s disease (PD). The mechanisms underlying PD-related nigrostriatal neurodegeneration remain incompletely understood, with multiple factors modulating the course of PD pathogenesis. This includes Nrf2-dependent gene expression, oxidative stress, α-synuclein pathology, mitochondrial dysfunction, and neuroi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 48b4a64f-c5bf-5e8f-b3af-441e1997655f
DOI: 10.21203/rs.3.rs-2367066/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease.DOI 10.21203/rs.3.rs-2367066/v1Read

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of Parkinson’s diseaseSemantic proximity Read

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s DiseaseSemantic proximity Read

Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's diseaseSemantic proximity Read

The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's DiseaseSemantic proximity Read

Pharmacological Blocker of NF-κb and Mitochondrial Ros Restrict NLRP3 Inflammasome Activation and Rescue Dopaminergic Neurons in Vitro and in Vivo Parkinson’s DiseaseSemantic proximity Read

The Nrf2-NLRP3-Caspase1 axis mediates the neuroprotective effects of Celastrol in Parkinson's diseaseSemantic proximity Read

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic ImplicationsSemantic proximity Read

αS oligomers generated from polyunsaturated fatty acid and dopamine metabolite differentially interact with Aβ to enhance neurotoxicitySemantic proximity Read

Omega 3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical TrialsSemantic proximity Read

Activation of Nrf2 Neuroprotective Pathways for Treatment of Parkinson’s Disease: A State of Art ReviewSemantic proximity Read

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant responseSemantic proximity Read

Nrf2: a modulator of Parkinson’s disease?Semantic proximity Read